IS VITAMIN D DEFICIENCY LINKED TO DEPRESSION? INSIGHTS FROM A NATIONALLY REPRESENTATIVE US SAMPLE

Background: Vitamin D deficiency (VDD) has been implicated in neuropsychiatric conditions, including depression, yet its relationship with specific depressive symptoms remains uncertain. This study investigates the association between VDD and individual depressive symptoms in a nationally representative U.S. population. Methods: We performed a retrospective cross-sectional analysis of 10,914 adults from the 2007–2018 NHANES cycles with complete serum 25-hydroxyvitamin D [25(OH)D] and depression screener (DPQ) data derived from the PHQ-9. VDD was defined as serum 25(OH)D <30 ng/mL. Depressive symptoms assessed were little interest, feeling down, low energy, negative self-image, and suicidal ideation. Multivariable logistic regression was conducted adjusting for age, gender, BMI, diabetes, hypertension, triglycerides, and other covariates. Results: VDD was present in 8% of participants and was more common among women, younger adults, and individuals with obesity. Depressive symptoms including little interest (29.9% vs. 24.8%), feeling down (30.4% vs. 24.5%), and low energy (55.0% vs. 48.9%) were significantly more prevalent in the VDD group (p < 0.01). VDD was independently associated with higher odds of any depressive symptom (adjusted odds ratio [aOR] 1.18; 95% CI: 1.02–1.36; p = 0.028). Stronger predictors included female gender (aOR 1.78), age <60 (aOR 1.49), obesity (aOR 1.21), diabetes (aOR 1.32), and hypertension (aOR 1.25). Conclusion: VDD is modestly but significantly associated with specific depressive symptoms, particularly anhedonia and fatigue. While the effect size is smaller than other metabolic and demographic factors, VDD may represent a modifiable target for future preventive mental health strategies.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-01
DOI
https://doi.org/10.5281/zenodo.17275448
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IS VITAMIN D DEFICIENCY LINKED TO DEPRESSION? INSIGHTS FROM A NATIONALLY REPRESENTATIVE US SAMPLE

Zenodo (CERN European Organization for Nuclear Research)
Vaccine Coverage and Hesitancy
article

IS VITAMIN D DEFICIENCY LINKED TO DEPRESSION? INSIGHTS FROM A NATIONALLY REPRESENTATIVE US SAMPLE

article en

Abstract

Background: Vitamin D deficiency (VDD) has been implicated in neuropsychiatric conditions, including depression, yet its relationship with specific depressive symptoms remains uncertain. This study investigates the association between VDD and individual depressive symptoms in a nationally representative U.S. population. Methods: We performed a retrospective cross-sectional analysis of 10,914 adults from the 2007–2018 NHANES cycles with complete serum 25-hydroxyvitamin D [25(OH)D] and depression screener (DPQ) data derived from the PHQ-9. VDD was defined as serum 25(OH)D <30 ng/mL. Depressive symptoms assessed were little interest, feeling down, low energy, negative self-image, and suicidal ideation. Multivariable logistic regression was conducted adjusting for age, gender, BMI, diabetes, hypertension, triglycerides, and other covariates. Results: VDD was present in 8% of participants and was more common among women, younger adults, and individuals with obesity. Depressive symptoms including little interest (29.9% vs. 24.8%), feeling down (30.4% vs. 24.5%), and low energy (55.0% vs. 48.9%) were significantly more prevalent in the VDD group (p < 0.01). VDD was independently associated with higher odds of any depressive symptom (adjusted odds ratio [aOR] 1.18; 95% CI: 1.02–1.36; p = 0.028). Stronger predictors included female gender (aOR 1.78), age <60 (aOR 1.49), obesity (aOR 1.21), diabetes (aOR 1.32), and hypertension (aOR 1.25). Conclusion: VDD is modestly but significantly associated with specific depressive symptoms, particularly anhedonia and fatigue. While the effect size is smaller than other metabolic and demographic factors, VDD may represent a modifiable target for future preventive mental health strategies.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 40%
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

IS VITAMIN D DEFICIENCY LINKED TO DEPRESSION? INSIGHTS FROM A NATIONALLY REPRESENTATIVE US SAMPLE · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS